ArticleMolecular carcinogenesis2026
Ubiquitin Specific Peptidase 48 Deubiquitinates METTL3 to Modulate Ferroptosis in Gastric Cancer Cells.
Article in Molecular carcinogenesis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ubiquitin Specific Peptidase 48 Deubiquitinates METTL3 to Modulate Ferroptosis in Gastric Cancer Cells.Molecular carcinogenesis · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Ferroptosis, an iron-dependent cell death, is a promising target in gastric cancer. METTL3, an m6A RNA methyltransferase, drives tumor progression, but its role in ferroptosis regulation and the involved deubiquitinating enzymes (DUBs) remain unclear. Here, we demonstrated that METTL3 expression heterogeneity in different gastric cancer cells, identified functional role of METTL3 in modulating ferroptosis sensitivity. In MKN-7 and GCIY cells, forced METTL3 overexpression conferred resistance to ferroptotic stress by driven GPX4 and FTH1 expression, and inhibiting oxidative stress accumulation. Conversely, METTL3 depletion sensitized cells to ferroptosis, and promoted ferroptotic oxidative damage. Through a comprehensive screening of deubiquitinases, we identified ubiquitin specific peptidase 48 (USP48) as a critical stabilizer of METTL3 protein. Functional assays revealed that USP48 mimics METTL3's protective role against ferroptosis, while METTL3 overexpression rescued the ferroptosis sensitivity caused by USP48 knockdown. Mechanistically, this USP48-METTL3 axis regulated key ferroptosis markers including GPX4, FTH1, lipid peroxidation, iron accumulation, and reactive oxygen species (ROS) levels. Our findings reveal a novel regulatory pathway by which USP48 controls ferroptosis sensibility in gastric cancer cell via METTL3 stabilization. This crosstalk between the ubiquitin-proteasome system and m6A transferases highlights the USP48-METTL3 axis as a promising target to sensitize gastric cancer cells to ferroptosis-inducing therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.